TY  - BOOK
AU  - 
ED  - SpringerLink (Online service)
TI  - Cancer
T2  - Topics in Medicinal Chemistry,
SN  - 9783540331209
AV  - RS400-431 
U1  - 615.19 23
PY  - 2007///
CY  - Berlin, Heidelberg
PB  - Springer Berlin Heidelberg, Imprint: Springer
KW  - Chemistry
KW  - Medicine
KW  - Toxicology
KW  - Chemistry, Organic
KW  - Biochemistry
KW  - Medicinal Chemistry
KW  - Pharmacology/Toxicology
KW  - Organic Chemistry
KW  - Molecular Medicine
N1  - Overview -- Anti-hormone Therapy: Principles of Endocrine Therapy of Cancer -- Inhibition of Growth Factor Signaling by Small-Molecule Inhibitors of ErbB, Raf, and MEK -- Farnesyl Protein Transferase Inhibitors: Medicinal Chemistry, Molecular Mechanisms, and Progress in the Clinic -- Survival Signaling -- Progress in the Development of Agents to Control the Cell Cycle -- HDAC Inhibition in Cancer Therapy: An Increasingly Intriguing Tale of Chemistry, Biology and Clinical Benefit -- Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor Receptor 2 for Cancer Therapy -- Novel Small-Molecule Inhibitors of Src Kinase for Cancer Therapy -- Bcr-Abl Kinase Inhibitors; ZDB-2-CMS
UR  - http://dx.doi.org/10.1007/978-3-540-33120-9
ER  -